Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Aquestive Therapeutics Announces Leadership Expansion to Support Growth GlobeNewswire - Tue Nov 4, 2025

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company’s ongoing development initiatives  ...

TLSA : 1.3400 (+4.69%)
AQST : 4.20 (+2.44%)
Tiziana Life Sciences Reports Interim Results and Expands U.S. Presence Tipranks - Sat Oct 4, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Tiziana Life...

TLSA : 1.3400 (+4.69%)
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week Stocktwits - Sun Mar 2, 2025

New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025.

TLSA : 1.3400 (+4.69%)
AIM : 0.5153 (-0.64%)
PEPG : 1.7500 (+6.71%)
AEON : 0.8900 (-3.58%)
MBRX : 2.51 (-1.95%)
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Quiver Quantitative, Inc. - Wed Dec 4, 2024

Tiziana Life Sciences expands Phase 2 trial for intranasal foralumab in non-active secondary progressive multiple sclerosis across prominent Northeast institutions.Quiver AI SummaryTiziana Life Sciences,...

TLSA : 1.3400 (+4.69%)
Tiziana Life Sciences Receives ALS Association Grant to Advance Clinical Trial of Intranasal Foralumab for ALS Treatment Quiver Quantitative, Inc. - Tue Nov 19, 2024

Tiziana Life Sciences receives funding from the ALS Association for a clinical trial of intranasal foralumab in ALS patients.Quiver AI SummaryTiziana Life Sciences, a biotechnology company focused on immunomodulation...

TLSA : 1.3400 (+4.69%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises FinancialNewsMedia - Tue Jun 11, 2024

EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END

TGTX : 33.85 (+0.21%)
TLSA : 1.3400 (+4.69%)
LLY : 963.33 (+3.07%)
RHHBY : 51.0000 (+0.24%)
BIIB : 187.06 (-1.17%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises GlobeNewswire - Tue Jun 11, 2024

TGTX : 33.85 (+0.21%)
TLSA : 1.3400 (+4.69%)
LLY : 963.33 (+3.07%)
RHHBY : 51.0000 (+0.24%)
BIIB : 187.06 (-1.17%)
Tiziana Life Sciences Appoints Matthew W. Davis, MD, RPh as Chief Medical Officer and Acting Chief Scientific Officer Globe Newswire - Mon Jul 18, 2022

NEW YORK, July 18, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling...

TLSA : 1.3400 (+4.69%)
TILS.LN : 58.500 (+8.33%)
Tiziana Life Sciences Announces Resignation of CEO Globe Newswire - Fri Jul 15, 2022

NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling...

TLSA : 1.3400 (+4.69%)
TILS.LN : 58.500 (+8.33%)
Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice Globe Newswire - Fri Jun 17, 2022

NEW YORK, June 17, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling...

TLSA : 1.3400 (+4.69%)
TILS.LN : 58.500 (+8.33%)

Barchart Exclusives

McDonald’s Is Down 4% and Starbucks Is Up 25% in 2026. The Better Dividend Stock Might Surprise You. Barchart - Fri May 1, 6:00PM CDT
Starbucks is up 25% in 2026 while McDonald's slipped 4%. So why might McDonald's still be the smarter dividend buy? The numbers tell a story most investors are missing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.